Godrej Consumer Products posted 13.8% profit growth to ₹522.92 crore and 19% revenue growth to ₹4,413.09 crore in Q2 FY27. Strong internati...

Chinese stocks declined as a sharp selloff in technology and AI-related shares outweighed the US Federal Reserve’s decision to keep interes...

Tobacco major Philip Morris International (PMI) reported a 5.5 per cent YoY rise in net revenues to $11.4 billion in Q3, driven by growth i...

Jefferies has initiated coverage on NSE with a ‘Buy’ rating and a target price of Rs 2,085, indicating over 17% upside. The brokerage expec...

Hero MotoCorp’s Q2 FY27 consolidated profit rose 41% to Rs 1,860.55 crore, while revenue increased 23% to Rs 14,970.50 crore. Scooter sales...

Hero MotoCorp’s Q2 FY27 consolidated profit rose 41% to Rs 1,861 crore, while revenue increased 23% to Rs 14,971 crore. Scooter sales, 100c...

HUL Q2 Results: Hindustan Unilever reported a 4% year-on-year rise in Q2 FY27 net profit to Rs 2,790 crore, while revenue grew 15% to Rs 18...

BNP Paribas reported a 14% year-on-year rise in third-quarter net income to €3.46 billion, beating analyst estimates as record equity tradi...

JIo IPO Listing: In a landmark event, Jio Platforms' shares are set to launch in the stock market today after a historic IPO. The exception...

Happy Wednesday! Cognizant has held discussions to invest in homegrown AI startup Sarvam. This and more in today’s ETtech Morning Dispatch.

Cipla's September-quarter earnings suffered due to a high base in its US business. The company reported sequential growth driven by its str...

Reliance Jio and Bharti Airtel reported similar subscriber gains in September as Reliance Jio added 2.71 million users. Bharti Airtel follo...

Cipla reported a 35% drop in consolidated net profit for Q2FY27, which stood at Rs 878 crore. The company also experienced a 2.4% year-on-y...

Mankind Pharma shares jumped nearly 8% after the company reported a 38% year-on-year rise in Q2 profit to Rs 716 crore. Revenue grew 17%, s...

Jefferies sees a wide risk-reward range for Vodafone Idea, forecasting up to 143% upside in its bull case and 25% downside in its bear case...

The company outperformed the market by 1.1 times in both chronic and acute therapies. Cardiac and anti-diabetes brands registered growth of...

China and Hong Kong stocks weakened on Tuesday, joining a broader retreat in the region, after Beijing kept key lending rates unchanged and...